The critical role of evidence-based databases in pharmacogenomics

In the high-stakes field of pharmacogenomics (PGx), precision and accuracy are non-negotiable. Evidence-based databases in PGx are indispensable tools that enable labs to interpret genetic variants confidently and accurately.

Trusted databases, such as PharmVar, CPIC, and PubMed, serve as vital resources for interpreting the impact of genetic variations on drug response. However, leveraging these databases effectively — and avoiding outdated or low-quality sources – is essential to ensuring the most accurate, relevant, and timely care.

Explore Pharmacogenomic Insights (PGXI) – a streamlined knowledgebase from QIAGEN^® that can efficiently submit test results to identify relevant gene-drug associations, conditions, and literature evidence.